Crossmark

CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer

Crossref DOI link: https://doi.org/10.1186/s13046-019-1087-1

Published Online: 2019-02-20

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Morra, Francesco

Merolla, Francesco

Criscuolo, Daniela

Insabato, Luigi

Giannella, Riccardo

Ilardi, Gennaro

Cerrato, Aniello

Visconti, Roberta

Staibano, Stefania

Celetti, Angela http://orcid.org/0000-0001-5166-3507
Funding

Funding for this research was provided by:

Associazione Italiana per la Ricerca sul Cancro (4592)

Regione Campania (POR Campania FSE 2007/2013)

Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2009T5NKTB_002)
License Information

Text and Data Mining valid from 2019-02-20
More Information

Article History

Received: 28 December 2018

Accepted: 6 February 2019

First Online: 20 February 2019

Ethics approval and consent to participate

: The study design and procedures involving tissue samples collection and handling were performed according to the Declaration of Helsinki, in agreement with the current Italian law, and to the Institutional Ethical Committee guidelines.

: Not applicable.

: The authors declare that they have no competing interests

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.